Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer’s disease-type beta-amyloid neuropathological mechanisms

References

• Li D, Wang P, Wang P, et al. The gut microbiota: a treasure for human health. Biotechnol Adv. 2016;34(7):1210–1224.
   PubMed Web of Science ®Google Scholar
• Scheperjans F, Aho V, Pereira PA, et al. Gut microbiota are related to Parkinson’s disease and clinical phenotype. Mov Disord. 2015;30(3):350–358.
   PubMed Web of Science ®Google Scholar
• Sherwin E, Dinan TG, Cryan JF. Recent developments in understanding the role of the gut microbiota in brain health and disease. Ann N Y Acad Sci 2017;1406 [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Wu SC, Cao ZS, Chang KM, et al. Intestinal microbial dysbiosis aggravates the progression of Alzheimer’s disease in Drosophila. Nat Commun. 2017;8(1):24.
   PubMed Web of Science ®Google Scholar
• Sanchez B, Delgado S, Blanco-Miguez A, et al. Probiotics, gut microbiota, and their influence on host health and disease. Mol Nutr Food Res. 2017;61(1):1600240.
   Web of Science ®Google Scholar
• Koh A, De Vadder F, Kovatcheva-Datchary P, et al. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165(6):1332–1345.
   PubMed Web of Science ®Google Scholar
• Den Besten G, Van Eunen K, Groen AK, et al. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013;54(9):2325–2340.
   PubMed Web of Science ®Google Scholar
• Mori T, Koyama N, Guillot-Sestier MV, et al. Ferulic acid is a nutraceutical β-secretase modulator that improves behavioral impairment and Alzheimer-like pathology in transgenic mice. PLoS One. 2013;8(2):e5574.
   Web of Science ®Google Scholar
• Oboh G, Agunloye OM, Akinyemi AJ, et al. Comparative study on the inhibitory effect of caffeic and chlorogenic acids on key enzymes linked to Alzheimer’s disease and some pro-oxidant induced oxidative stress in rats’ brain-in vitro. Neurochem Res. 2013;38(2):413–419.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang Y, Li J, et al. Effects of caffeic acid on learning deficits in a model of Alzheimer’s disease. Int J Mol Med. 2016;38(8):869–875.
   PubMedGoogle Scholar
• Clifford MN. Diet-derived phenols in plasma and tissues and their implications for health. Planta Med. 2004;70(12):1103–1114.
   PubMed Web of Science ®Google Scholar
• Monagas M, Uri-Sarda M, Sanchez-Patan F, et al. Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites. Food Funct. 2010;1(3):233–253.
   PubMed Web of Science ®Google Scholar
• Vetrani C, Rivellese AA, Anuzzi G, et al. Metabolic transformations of dietary polyphenols: comparison between in vitro colonic and hepatic models and in vivo urinary metabolites. J Nutr Biochem. 2016;33:111–118.
   PubMed Web of Science ®Google Scholar
• Menendez JA, Vazquez-Martin A, Oliveras-Ferraros C, et al. Analyzing effects of extra-virgin olive oil polyphenols on breast cancer-associated fatty acid synthase protein expression using reverse-phase protein microarrays. Int J Mol Med. 2008;22(4):433–439.
   PubMed Web of Science ®Google Scholar
• Xie L, Lee SG, Vance TM, et al. Bioavailability of anthocyanins and colonic polyphenol metabolites following consumption of aronia berry extract. Food Chem. 2016;211:860–868.
   PubMed Web of Science ®Google Scholar
• Sadeghi ES, Sleno L, Sabally K, et al. Biotransformation of polyphenols in a dynamic multistage gastrointestinal model. Food Chem. 2016;204:453–462.
   PubMed Web of Science ®Google Scholar
• Wang D, Ho L, Faith J, et al. Role of intestinal microbiota in the generation of polyphenol-derived phenolic acid mediated attenuation of Alzheimer’s disease β-amyloid oligomerization. Mol Nutr Food Res. 2015;59(6):1025–1040.
   PubMed Web of Science ®Google Scholar
• Macfarlane GT, Bacteria MS. Colonic fermentation, and gastrointestinal health. J AOAC Int. 2012;95(1):50–60.
   PubMed Web of Science ®Google Scholar
• Cummings JH, Pomare EW, Branch WJ, et al. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 1987;28(10):1221–1227.
   PubMed Web of Science ®Google Scholar
• Zilberter Y, ZIlberter M. The vicious circle of hypometabolism in neurodegenerative diseases: ways and mechanisms of metabolic correction. J Neurosci Res. 2017; 95(11):2217–2235.
   Google Scholar
• Erny D, Hrabe De Angelis AL, Jaitin D, et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci. 2015;18:96–5977.
   Web of Science ®Google Scholar
• Martins IJ, Wmad BF. High fiber diets and Alzheimer’s disease. Food and Nutr Sci. 2014;5(4):410–424.
   Google Scholar
• Walsh DM, Lomakin A, Benedek GB, et al. Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. J Biol Chem. 1997;272(35):22364–22372.
   PubMed Web of Science ®Google Scholar
• Teplow DB. Preparation of amyloid beta-protein for structural and functional studies. Methods Enzymol. 2006;413:20–33.
   PubMed Web of Science ®Google Scholar
• Ono K, Condron MM, Ho L, et al. Effects of grape seed-derived polyphenols on amyloid beta-protein self-assembly and cytotoxicity. J Biol Chem. 2008;283(47):32176–32187.
   PubMed Web of Science ®Google Scholar
• Bitan G, Tarus B, Vollers SS, et al. A molecular switch in amyloid assembly: met35 and amyloid beta-protein oligomerization. J Am Chem Soc. 2003;125(50):15359–15365.
   PubMed Web of Science ®Google Scholar
• Bitan G, Fradinger EA, Spring SM, et al. Neurotoxic protein oligomers – what you see is not always what you get. Amyloid. 2015;12(2):88–95.
   Google Scholar
• LeVine H. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 1999;309:274–284.
   PubMed Web of Science ®Google Scholar
• Kumar V, Sami N, Kashav T, et al. Protein aggregation and neurodegenerative diseases: from theory to therapy. Eur J Med Chem. 2016;124:1105–1120.
   PubMed Web of Science ®Google Scholar
• Shamsi TN, Athar T, Parveen R, et al. A review on protein misfolding, aggregation and strategies to prevent related ailments. Int J Biol Macromol. 2017;105(Pt 1):993–1000.
   Google Scholar
• Forloni G, Artuso V, La Vitola P, et al. Oligomeropathies and pathogenesis of Alzheimer and Parkinson’s diseases. Mov Disord. 2016;31(6):771–781.
   PubMed Web of Science ®Google Scholar
• Pula JH, Kim J, Nichols J. Visual aspects of neurologic protein misfolding disorders. Curr Opin Ophthalmol. 2009;20(6):482–489.
   PubMed Web of Science ®Google Scholar
• Ugalde CL, Finkelstein DI, Lawson VA, et al. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers. J Neurochem. 2016;139(2):162–180.
   PubMed Web of Science ®Google Scholar
• Plagg B, Ehrlich D, Kniewallner KM, et al. Increased acetylation of histone H4 at lysine 12 (H4K12) in monocytes of transgenic Alzheimer’s mice and in human patients. Curr Alzheimer Res. 2015;12(8):752–760.
   PubMed Web of Science ®Google Scholar